Spontaneous release of leukemia inhibitory factor and oncostatin-M is increased in supernatants of short-term organ cultures from lesional psoriatic skin

Archives of Dermatological Research

Volumn 290, Issue 1-2, 1998, Pages 9-13

  Bonifati, C ^a   Mussi, A ^a   D'Auria, L ^a   Carducci, M ^a   Trento, E ^a   Cordiali Fei, P ^a   Ameglio, F ^a  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

IL 8; LIF; Organ culture; OSM; Psoriasis; Supernatant

Indexed keywords

CYTOKINE; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; ORGAN CULTURE; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MALE; MIDDLE AGED; ONCOSTATIN M; ORGAN CULTURE TECHNIQUES; PEPTIDES; PSORIASIS; TIME FACTORS;

EID: 0031931223     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050269     Document Type: Article

References (37)

1. Gearing DP (1993) The leukemia inhibitory factor and its receptor. Adv Immunol 53: 31-58
2. Callard R, Gearing A (1994) LIF. The cytokine facts book. Harcourt Brace, London, pp 163-164
3. Villiger PM, Geng Y, Lotz M (1993) Induction of cytokine expression by leukemia inhibitory factor. J Clin Invest 91: 1571-1581
4. Mckenzie RC, Paglia D, Kondo S, Sauder DN (1996) A novel endogenous mediator of cutaneous inflammation: leukemia inhibitory factor. Acta Derm Venereol (Stockh) 76: 110-114
5. Callard R, Gearing A (1994) OSM. The cytokine facts book. Harcourt Brace, London, pp 207-209
6. Thèze J (1994) Cytokine receptors: a combinative family of molecules. Eur Cytokine Netw 5: 353-368
7. Waring P, Wycherley K, Cary D, Nicola N, Metcalf D (1992) Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. J Clin Invest 90: 2031-2037
8. Wallace PM, Mcmaster JF, Rillema JR, Rouleau KA, Hanson MB, Burstein A, Shoiab M (1995) In vivo properties of oncostatin M. Ann N Y Acad Sci 762: 43-53
9. Richards CD, Langdon C, Botelho F, Brown TJ, Agro A (1996) Oncostatin M inhibits IL-1-induced expression of IL-8 and granulocyte-macrophage colony-stimulating factor. J Immunol 156: 343-349
10. Hirano T, Akira S, Taga T, Kishimoto T (1990) Biological and clinical aspects of interleukin-6. Immunol Today 11: 443-449
11. Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb AB (1989) Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86: 6367-6371
12. Bonifati C, Ameglio, F, Carducci, M, Sacerdoti G, Pietravalle M, Fazio M (1994) Interleukin-1-beta, interleukin-6 and interferon-gamma in suction blister fluids of involved and uninvolved skin and sera of psoriatic patients. Acta Derm Venereol Suppl (Stockh) 186: 23-24
13. Bonifati C, Carducci M, Cordiali-Fei P, Trento E, Sacerdoti G, Fazio M, Ameglio F (1994) Correlated increases of tumor necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients: relationships with disease severity. Clin Exp Dermatol 19: 383-387
14. Beyaert R, Schulze-Osthoff K, van Roy F, Fiers W (1992) Synergistic induction of interleukin-6 by tumor necrosis factor and lithium chloride in mice: possible role in the triggering and exacerbation of psoriasis by lithium treatment. Eur J Immunol 22: 2181-2184
15. Ameglio F, Bonifati C, Fazio M, Mussi A, Trento E, Cordiali-Fei P, Donati P, Pimpinelli F, D'Auria L, Carduci M (1997) Interleukin-11 production is increased in organ cultures of lesional skin of patients with plaque-type psoriasis as compared with non-lesional and normal skin. Similarity to interleukin-1beta, interleukin-6 and interleukin-8. Arch Dermatol Res 289: 399-403
16. D'Auria L, Bonifati C, Mussi A, D'Agosto G, De Simone C, Giacalone B, Ferraro C, Ameglio F (1998) Cytokines in the sera of patients with pemphigus vulgaris: IL-6 and TNF-alpha levels are significantly increased as compared to healthy subjects and correlated with disease activity. Eur Cytokine Network (in press)
17. Ameglio F, D'Auria L, Bonifati C, Ferraro C, Mastroianni A, Giacalone B (1998) Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity. Brit J Dermatol (in press)
18. Nickoloff BJ, Karabin GD, Barker JNWN, Griffiths CEM, Sarma V, Mitra RS, Elder JT, Kunkel SL, Dixit VM (1991) Cellular localization of interleukin-8 and its inducer tumor necrosis factor in psoriasis. Am J Pathol 138: 129-140
19. Nickoloff BJ, Mitra RS, Varani J, Dixit VD, Polverini PJ (1994) Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol 144: 820-828
20. Fredrikson T, Patterson U (1978) Severe psoriasis oral therapy with a new retinoid. Dermatologica 157: 238-244
21. Yoshinaga Y, Higaki M, Terajima S, Ohkubo E, Nogita T, Miyasaka N, Kawashima M (1995) Detection of inflammatory cytokines in psoriatic skin. Arch Dermatol Res 287: 158-164
22. Lefebvre d'Hellencourt C, Diaw L, Guenounou M (1995) Immunomodulation by cytokine antisense oligonucleotides. Eur Cytokine Netw 6:7-19
23. Nickoloff BJ (991) The cytokine network in psoriasis. Arch Dermatol 127: 871-884
24. Debets R, Hengmans JPJJ, Troost RJJ, Benner R, Prens EP (1995) Enhanced production of biologically active interleukin-1 alpha and interleukin-1beta by psoriatic epidermal cells ex vivo: evidence of increased cytosolic interleukin-1beta levels and facilitated interleukin-1 release. Eur J Immunol 25: 1624-1630
25. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ (1993) The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 101:701-705
26. Bonifati C, Trento E, Cordiali-Fei P, Carducci M, Mussi A, D'Auria L, Pimpinelli F, Fazio M, Ameglio F (1997) Increased interleukin-7 concentrations in lesional skin and in the sera of patients with plaque type psoriasis. Clin Immunol Immunopathol 83: 41-44
27. Kojima T, Cromie MA, Fisher GJ, Voorhees JJ, Elder JT (1993) GRO-alpha mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporin A in vivo but not in cultured keratinocytes. J Invest Dermatol 101: 767-772
28. Gillitzer R, Wolff K, Tong D (1993) MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 101: 127-131
29. Elder JT, Fisher GJ, Lindquist PB, Bennet GE, Pittelkow MR, Coffey RJ, Ellingsworth L, Dernynck R, Voorhee JJ (1989) Overexpression of transforming growth factor alpha in psoriatic epidermis. Science 243: 811-814
30. Lotz M, Moats T, Villiger PM (1992) Leukemia inhibitory factor is expressed in cartilage and synovium. J Clin Invest 90: 888-896
31. Musso T, Badolato R, Longo DE, Gusella GL, Varesio L (1995) Leukemia inhibitory factor induces interleukin-8 and chemotactic and activating factor in human monocytes: differential regulation by interferon-gamma. Blood 86: 1961-1967
32. Metcalf D (1991) The leukemia inhibitory factor (LIF). Int J Cell Cloning 9: 95-108
33. Szepietowski JC, McKenzie RC, Keohane SG, Walker C, Aldridge RD, Hunter JA (1997) Leukemia inhibitory factor: induction in the early phase of allergic contact dermatitis. Contact Dermatitis 36: 21-25
34. Brown TJ, Liu J, Brashem-Stein C, Shoyab M (1993) Regulation of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor expression by oncostatin M. Blood 82: 33-37
35. Brown TJ, Rowe JM, Liu JW, Shoyab M (1991) The regulation of IL-6 expression by oncostatin M. J Immunol 147: 2175-2180
36. Lowe PM, Lee ME, Jackson CJ, To SST, Cooper AJ, Schrieber L (1995) The endothelium in psoriasis. Br J Dermatol 132: 497-505
37. Bonifati C, Trento E, Carducci M, Sacerdoti G, Mussi A, Fazio M, Ameglio F (1995) Soluble E-selectin and soluble tumor necrosis factor receptor (60 kD) serum levels in patients with psoriasis. Dermatology 190: 128-131